<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">906</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2021-3-54-55</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Glycemia under control</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kalinina</surname><given-names>Nadezhda</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">RM Analytics</aff><pub-date date-type="epub" iso-8601-date="2021-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2021</year></pub-date><issue>3</issue><fpage>54</fpage><lpage>55</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2021,</copyright-statement><copyright-year>2021</copyright-year></permissions><abstract>Diabetes mellitus (DM) has become a global and national menace. The number of patients with diabetes in the Russian Federation tallied roughly 5.1 million, according to the incidence of outpatient visits in 2020 [1]. “Do-it-yourself” regular measurements of blood glucose levels (self-monitoring) are one of the most important components in achieving the therapy goals for patients with diabetes and preventing severe vascular complications. Now that the technologies have caught on, new “smart” glucometers appeared, which enable remote control and significantly expand opportunities of DM monitoring due to free mobile application integration.</abstract><kwd-group xml:lang="en"><kwd>diabetes mellitus</kwd><kwd>glucometer</kwd><kwd>glycated hemoglobin (HbA1c)</kwd><kwd>Contour Plus</kwd><kwd>Contour Plus One</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>сахарный диабет</kwd><kwd>глюкометр</kwd><kwd>гликированный гемоглобин (HbA1c)</kwd><kwd>Контур Плюс</kwd><kwd>Контур Плюс Уан</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Число россиян с сахарным диабетом выросло до 5,1 млн. Режим доступа: https://tass.ru.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Хайбулина Э.Т., Мамонов Р.А., Горст К.А., Тимофеев А.В. Оценка аналитической и клинической точности трех систем контроля уровня глюкозы в крови. Эффективная фармакотерапия. Эндокринология. 2014;53(6).</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Caswell M., Frank J., Viggiani M.T. et al. Accuracy and user performance evaluation of a blood glucose monitoring system. Diabetes Technol Ther. 2015;17(3):152–158.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Frank J., Wallace J.F., Pardo S., Parkes J.L. Performance of the CONTOUR® TS Blood Glucose Monitoring System. J Diabetes Sci Technol. 2011;5(1):198–205.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Шестакова М.В., Викулова О.К., Исаков М.А., Дедов И.И. Сахарный диабет и COVID-19: анализ клинических исходов по данным регистра сахарного диабета Российской Федерации . Проблемы эндокринологии. 2020;66(1):112–123. https://doi.org/10.14341/probl12458.</mixed-citation></ref></ref-list></back></article>
